Evidence map›Paper›PMID 10081611›Full record

ArticleCellular and molecular neurobiology1999

Tyrosines 905 and 915 of gp130 are required for maximum induction of m2 muscarinic acetylcholine receptor and VIP gene transcription by cytokines in neuronal cells.

M L Rosoff, N M Nathanson

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M L RosoffDepartment of Pharmacology, University of Washington, Seattle 98195-7750, USA.
N M Nathanson
University of Washington · US

Funding

NINDS NIH HHS NS07332NINDS NIH HHS NS30410
6 · The paper itself

Abstract

1. Leukemia inhibitory factor action is mediated by a heterodimeric receptor consisting of two subunits, gp130 and the low-affinity leukemia inhibitory factor receptor (LIFR). 2. We used chimeric receptors containing the intracellular domain of either the LIFR or gp130 to identify regions of the receptors required for induction of the m2 muscarinic acetylcholine receptor gene in IMR-32 and SN56 neuronal cells. 3. While chimeric receptors containing the intracellular domain of gp130 were able to induce transcription from both the m2 and the vasoactive intestinal peptide (VIP) gene promoters, chimeric receptors containing the intracellular domain of the LIFR were incapable of mediating induction of the m2 gene despite being able to induce VIP transcription. 4. Deletion and mutagenesis studies identified two tyrosines, Y905 and Y915, which were required for maximal induction of the m2 and VIP genes. 5. Because Y905 and Y915 are reported to be the only tyrosine residues in gp130 that bind Stat1, these results suggest that this transcription factor plays a key role in the induction of transcription of both the m2 and the VIP genes.

Indexed as

Trans-ActivatorsCalcium-Calmodulin-Dependent Protein KinasesCell LineCiliary Neurotrophic FactorContactinsDNA-Binding ProteinsGene Expression Regulation, EnzymologicGenes, ReporterMutagenesisNerve Tissue ProteinsNeural Cell Adhesion MoleculesNeuronsNeurotransmitter AgentsPromoter Regions, GeneticReceptor, Muscarinic M2Receptors, MuscarinicCalcium-Calmodulin-Dependent Protein KinasesCiliary Neurotrophic FactorContactinsDNA-Binding ProteinsNerve Tissue ProteinsNeural Cell Adhesion MoleculesNeurotransmitter AgentsReceptor, Muscarinic M2Receptors, MuscarinicRecombinant Fusion ProteinsSTAT3 Transcription FactorTrans-ActivatorsTyrosineVasoactive Intestinal Peptide

Identifiers

PMID10081611
PMCPMC11545653
OpenAlexW123560592

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.